NRAS and acute lymphoblastic leukemia: To this end, we retrospectively evaluated the impact of RAS mutations on children with ALL enrolled onto CCCG-ALL-2015 clinical trial and tested the contributions of NRAS mutations on ALL leukemogenesis and drug response.